Early transplant related mortality in lymphoma patients undergoing autologous hematopoietic stem cell transplantation after conditioning with CBV (cyclophosphamide, carmustine and etoposide)

被引：0
|
作者：
Regadera, A
Jarque, I
de la Rubia, J
Andreu, R
Garcia, I
Moscardó, F
Mena, A
Yuste, A
Jimenez, C
Martín, G
Martínez, J
Sanz, G
Saavedra, S
Mollá, S
Plumé, G
Sanz, MA
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [21] Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients
    Jung Yoon Choi
    Hyoung Jin Kang
    Hong Yul An
    Kyung Taek Hong
    Hee Young Shin
    International Journal of Hematology, 2020, 111 : 877 - 887
  • [22] Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation
    J de la Rubia
    S Saavedra
    GF Sanz
    G Martín
    F Moscardó
    J Martínez
    I Jarque
    C Jiménez
    MA Sanz
    Bone Marrow Transplantation, 2001, 27 : 21 - 25
  • [23] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [24] Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation
    de la Rubia, J
    Saavedra, S
    Sanz, GF
    Martín, G
    Moscardó, F
    Martínez, J
    Jarque, I
    Jiménez, C
    Sanz, MA
    BONE MARROW TRANSPLANTATION, 2001, 27 (01) : 21 - 25
  • [25] Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation
    Puig, Noemi
    De La Rubia, Javier
    Remigia, Maria J.
    Jarque, Isidro
    Martin, Guillermo
    Cupelli, Luca
    Sanz, Guillermo F.
    Lorenzo, Ignacio
    Sanz, Jaime
    Martinez, Jesus A.
    Jimenez, Carmen
    Sanz, Miguel A.
    LEUKEMIA & LYMPHOMA, 2006, 47 (08) : 1488 - 1494
  • [26] Cisplatin as a Viable and Secure Alternative to Carmustine in BEAM-Based Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma
    Acosta-Maldonado, B. L.
    Padilla-Ortega, A.
    Fernandez-Vargas, O. E.
    Rivera-Fong, L.
    Valero-Saldana, L. M.
    Calderon-Flores, E.
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (06) : 1446 - 1453
  • [27] Comparison of the Tolerability of Busulfan, Cyclophosphamide, Etoposide (BuCyVP) Versus Carmustine, Etoposide, Cytarabine, Melphalan (BEAM) for Autologous Hematopoietic Cell Transplant (AHCT) in Hodgkin Lymphoma
    Urban, Theresa A.
    Lucena, Mariana
    Gaffney, Kelly
    Dean, Robert M.
    Gerds, Aaron T.
    Hamilton, Betty K.
    Jagadeesh, Deepa
    Kalaycio, Matt E.
    Pohlman, Brad
    Sobecks, Ronald M.
    Hill, Brian T.
    Rybicki, Lisa
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [28] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [29] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (02) : 116 - 117
  • [30] Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
    Cashen, Amanda F.
    Fletcher, Theresa
    Ceriotti, Connie
    Gao, Feng
    Ghobadi, Armin
    Vij, Ravi
    Stockerl-Goldstein, Keith
    DiPersio, John
    Abboud, Camille
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2155 - 2158
12345